Notes
2015 euros
Reference
Lewis A, et al. Budesonide + formoterol delivered via Spiromax(R) for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler(R). Respiratory Medicine 129: 179-188, Aug 2017. Available from: URL: http://doi.org/10.1016/j.rmed.2017.06.018
Rights and permissions
About this article
Cite this article
Switching from Turbuhaler to Spiromax cost saving. PharmacoEcon Outcomes News 784, 27 (2017). https://doi.org/10.1007/s40274-017-4238-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4238-7